NCT03089827
Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease
Enrolling by Invitation
Not specifiedAges 55+ObservationalWake Forest University Health SciencesInvestigator-initiated
~800 participants
Updated 2025-12-22 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Amyloid deposition
Measured over 2 years
Conditions
Where it's being run
1 sites across 1 statesNorth Carolina1
Study leadership
- Suzanne Craft, PhD · PRINCIPAL_INVESTIGATOR · Wake Forest University Health Sciences
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Enrolled in a study with the Alzheimer's Disease Research Center.
What this trial measures
- Amyloid deposition2 years
Studying the initial amyloid deposition in participants as well as their rate of amyloid accumulation over time will help establish whether there is an early therapeutic window for intervention in high risk patients.